Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $73,211 | 27 | 68.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,582 | 8 | 14.6% |
| Travel and Lodging | $9,935 | 28 | 9.3% |
| Food and Beverage | $5,315 | 94 | 5.0% |
| Honoraria | $1,500 | 1 | 1.4% |
| Education | $1,147 | 18 | 1.1% |
| Gift | $212.80 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $15,232 | 10 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $12,531 | 13 | $0 (2018) |
| PFIZER INC. | $11,728 | 8 | $0 (2022) |
| Novo Nordisk Inc | $8,409 | 39 | $0 (2023) |
| Gilead Sciences, Inc. | $7,465 | 4 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $7,376 | 15 | $0 (2018) |
| Boehringer Ingelheim International GmbH | $6,250 | 2 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $5,200 | 1 | $0 (2021) |
| Genentech, Inc. | $4,282 | 6 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $3,788 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,363 | 13 | Boehringer Ingelheim International GmbH ($6,250) |
| 2023 | $10,804 | 15 | Novo Nordisk Inc ($7,065) |
| 2022 | $5,653 | 11 | PFIZER INC. ($2,476) |
| 2021 | $14,631 | 9 | PFIZER INC. ($5,864) |
| 2020 | $4,447 | 22 | PFIZER INC. ($2,188) |
| 2019 | $13,288 | 24 | Gilead Sciences, Inc. ($7,400) |
| 2018 | $29,542 | 54 | Regeneron Healthcare Solutions, Inc. ($12,531) |
| 2017 | $18,174 | 30 | Alkermes, Inc. ($10,171) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Boston Scientific Corporation | Apollo ESG NXT System (Device) | Food and Beverage | In-kind items and services | $141.84 | General |
| Category: Apollo ESG NXT System_ENDO | ||||||
| 08/09/2024 | Gen-Probe, Inc. | — | Travel and Lodging | In-kind items and services | $200.64 | General |
| 08/09/2024 | Gen-Probe, Inc. | APTIMA (Device) | Food and Beverage | In-kind items and services | $60.47 | General |
| Category: Diagnostics | ||||||
| 08/05/2024 | Gen-Probe, Inc. | APTIMA (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Diagnostics | ||||||
| 07/16/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $41.04 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Hologic Sales and Service, LLC | APTIMA (Device), BTX | Travel and Lodging | In-kind items and services | $506.95 | General |
| Category: Diagnostics | ||||||
| 06/27/2024 | Hologic Sales and Service, LLC | BTX (Device), APTIMA | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: Surgical | ||||||
| 04/24/2024 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $35.62 | General |
| 04/22/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $4,160.00 | General |
| 04/22/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $2,090.03 | General |
| 02/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: UROLOGY | ||||||
| 01/10/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.29 | General |
| Category: Immunology | ||||||
| 11/03/2023 | Dr.Reddy's Laboratories,Inc. | HYDROXYCHLOROQUINE SULFATE (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Allergy and Immunology | ||||||
| 11/02/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $5,827.50 | General |
| 11/02/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $516.93 | General |
| 11/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $316.63 | General |
| 11/02/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $311.25 | General |
| 11/01/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $92.50 | General |
| 08/10/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $37.38 | General |
| Category: Hematology | ||||||
| 05/24/2023 | SANOFI-AVENTIS U.S. LLC | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $40.66 | General |
| Category: Rheumatology | ||||||
| 05/21/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Travel and Lodging | Cash or cash equivalent | $1,513.00 | General |
| Category: Hematology | ||||||
| 05/21/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: Hematology | ||||||
| 05/21/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $143.12 | General |
| Category: Hematology | ||||||
| 03/15/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $45.49 | General |
| Category: HORMONE THERAPY | ||||||
About Ross Miller
Ross Miller is a Public Health & General Preventive Medicine healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134209794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ross Miller has received a total of $106,903 in payments from pharmaceutical and medical device companies, with $10,363 received in 2024. These payments were reported across 178 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($73,211).
Practice Information
- Specialty Public Health & General Preventive Medicine
- Location Beverly Hills, CA
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 2083P0901X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134209794
Products in Payments
- LIBTAYO CEMIPLIMAB-RWLC INJECTION (Biological) $12,531
- Vivitrol 380 mg (Drug) $5,500
- OCREVUS (Biological) $4,282
- APTIMA (Device) $3,567
- ACCRUFER (Drug) $3,194
- SPINRAZA (Biological) $1,750
- Non-Covered Product (Drug) $1,575
- TOLVAPTAN (Drug) $1,225
- Repatha (Biological) $1,166
- GEMTESA (Drug) $1,075
- ENSTILAR (Drug) $750.00
- HYDROXYCHLOROQUINE SULFATE (Drug) $350.00
- Aristada 441 mg (Drug) $212.80
- Saxenda (Drug) $163.43
- Victoza (Drug) $161.35
- Xultophy 100/3.6 (Drug) $161.35
- DUPIXENT (Biological) $158.31
- Apollo ESG NXT System (Device) $141.84
- ENTRESTO (Drug) $110.78
- Levemir (Drug) $82.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.